• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG-related disease' by Simpson .

作者信息

Ebbo Mikael, De Sainte-Marie Benjamin, Muller Romain, Piperoglou Christelle, Grados Aurélie, Vély Frédéric, Schleinitz Nicolas

机构信息

Internal Medicine, AP-HM, Hôpital de la Timone, Marseille, France

Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.

出版信息

Ann Rheum Dis. 2022 Feb;81(2):e26. doi: 10.1136/annrheumdis-2020-217010. Epub 2020 Jan 29.

DOI:10.1136/annrheumdis-2020-217010
PMID:31996366
Abstract
摘要

相似文献

1
Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG-related disease' by Simpson .关于辛普森所著《度普利尤单抗作为一种用于IgG相关疾病的新型类固醇节省疗法》的通信
Ann Rheum Dis. 2022 Feb;81(2):e26. doi: 10.1136/annrheumdis-2020-217010. Epub 2020 Jan 29.
2
Response to: 'Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson ' by Ebbo .对埃博的回复：“关于辛普森的‘度普利尤单抗作为IgG4相关疾病的新型类固醇节省治疗药物’的通信” 。
Ann Rheum Dis. 2022 Feb;81(2):e27. doi: 10.1136/annrheumdis-2020-217029. Epub 2020 Mar 10.
3
Response to: 'Dupilumab as a steroid-sparing treatment for IgG4-related disease' by Della-Torre .对德拉 - 托雷的《度普利尤单抗作为IgG4相关疾病的类固醇节省治疗方法》的回应
Ann Rheum Dis. 2022 Feb;81(2):e25. doi: 10.1136/annrheumdis-2020-216955. Epub 2020 Feb 7.
4
Dupilumab as a steroid-sparing treatment for IgG4-related disease.度普利尤单抗作为IgG4相关性疾病的一种激素替代治疗药物。
Ann Rheum Dis. 2022 Feb;81(2):e24. doi: 10.1136/annrheumdis-2020-216945. Epub 2020 Jan 14.
5
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease.度普利尤单抗作为一种用于IgG4相关疾病的新型类固醇节省疗法。
Ann Rheum Dis. 2020 Apr;79(4):549-550. doi: 10.1136/annrheumdis-2019-216368. Epub 2019 Dec 19.
6
Response to : 'Interleukin-4 as a emerging target for IgG4-related disease' by Akiyama .对秋山所著《白细胞介素-4作为IgG4相关疾病的新兴靶点》的回应
Ann Rheum Dis. 2022 Feb;81(2):e29. doi: 10.1136/annrheumdis-2020-216977. Epub 2020 Feb 7.
7
A case of IgG4-related dacryoadenitis and sialoadenitis remitted by dupilumab monotherapy.1例经度普利尤单抗单药治疗缓解的IgG4相关性泪腺炎和涎腺炎病例。
Rheumatology (Oxford). 2024 May 3;63(6):e188-e189. doi: 10.1093/rheumatology/kead680.
8
[A CASE OF IgG4-RELATED DISEASE WITH CONFIRMED RESPONSE TO DUPILUMAB BY SMALL SALIVARY GLAND BIOPSY].[1例经小唾液腺活检证实对度普利尤单抗有反应的IgG4相关性疾病]
Arerugi. 2024;73(9):1158-1162. doi: 10.15036/arerugi.73.1158.
9
Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis.度普利尤单抗的疗效揭示了IgG4相关疾病的治疗靶点：同时控制炎症和纤维化。
Ann Rheum Dis. 2022 Mar;81(3):e50. doi: 10.1136/annrheumdis-2020-217076. Epub 2020 Feb 7.
10
IgG4-related disease administered dupilumab: case series and review of the literature.IgG4 相关疾病应用度普利尤单抗：病例系列和文献复习。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2023-003026.

引用本文的文献

1
A case of Dupilumab monotherapy in a patient with IgG4-related disease.一例使用度普利尤单抗单药治疗IgG4相关疾病患者的病例。
JAAD Case Rep. 2024 Mar 19;64:106-108. doi: 10.1016/j.jdcr.2024.03.007. eCollection 2025 Oct.
2
T cell immunophenotypes and IgE responses in patients with moderate-to-severe atopic dermatitis receiving dupilumab.接受度普利尤单抗治疗的中重度特应性皮炎患者的T细胞免疫表型和IgE反应
Clin Transl Allergy. 2025 May;15(5):e70062. doi: 10.1002/clt2.70062.
3
IgG4-related disease and other fibro-inflammatory conditions.
IgG4相关性疾病及其他纤维炎性疾病。
Nat Rev Rheumatol. 2025 May;21(5):275-290. doi: 10.1038/s41584-025-01240-x. Epub 2025 Apr 7.
4
Maternal, Fetal, and Labour Outcomes of Dupilumab Use for Atopic Dermatitis During Pregnancy: A Systematic Review.孕期使用度普利尤单抗治疗特应性皮炎的母体、胎儿及分娩结局：一项系统评价
J Cutan Med Surg. 2025 Jan-Feb;29(1):51-55. doi: 10.1177/12034754241290806. Epub 2024 Oct 20.
5
Pathogenic roles of follicular helper T cells in IgG4-related disease and implications for potential therapy.滤泡辅助 T 细胞在 IgG4 相关疾病中的致病作用及其对潜在治疗的影响。
Front Immunol. 2024 Jun 7;15:1413860. doi: 10.3389/fimmu.2024.1413860. eCollection 2024.
6
IgG4-related Disease: Recent Topics on Immunological Aspects of This Disorder and Their Application in New Treatment Strategies.IgG4相关性疾病：该疾病免疫方面的最新话题及其在新治疗策略中的应用
Intern Med. 2025 Jan 1;64(1):31-39. doi: 10.2169/internalmedicine.3154-23. Epub 2024 Feb 19.
7
A case of IgG4-related dacryoadenitis and sialoadenitis remitted by dupilumab monotherapy.1例经度普利尤单抗单药治疗缓解的IgG4相关性泪腺炎和涎腺炎病例。
Rheumatology (Oxford). 2024 May 3;63(6):e188-e189. doi: 10.1093/rheumatology/kead680.
8
Implication of allergy and atopy in IgG4-related disease.过敏和特应性在IgG4相关疾病中的意义。
World Allergy Organ J. 2023 Apr 17;16(4):100765. doi: 10.1016/j.waojou.2023.100765. eCollection 2023 Apr.
9
IgG4-related disease administered dupilumab: case series and review of the literature.IgG4 相关疾病应用度普利尤单抗：病例系列和文献复习。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2023-003026.
10
Immune dysregulation in immunoglobulin G4-related disease.免疫球蛋白G4相关疾病中的免疫失调。
Jpn Dent Sci Rev. 2023 Dec;59:1-7. doi: 10.1016/j.jdsr.2022.12.002. Epub 2023 Jan 9.